EMEA-002342-PIP02-18-M01

Invented name	Verzenios
Active substance	abemaciclib
Therapeutic area	Oncology
Decision number	P/0439/2021
PIP number	EMEA-002342-PIP02-18-M01
Pharmaceutical form(s)	Film-coated tablet Age-appropriate oral solid dosage form
Condition(s) / indication(s)	Treatment of glioma Treatment of neuroblastoma
Route(s) of administration	Oral use
Contact for public enquiries	Eli Lilly and Company Limited (US) Tel.: +1 31 75448941 E-mail: wagle_asvari@lilly.com
Decision type	PM: decision on the application for modification of an agreed PIP

Add your rating

★ ★ ★ ★ ★